Caxton Corp as of Dec. 31, 2018
Portfolio Holdings for Caxton Corp
Caxton Corp holds 25 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Strongbridge Bioph shs usd | 35.9 | $30M | 6.6M | 4.48 | |
| Mei Pharma | 11.1 | $9.1M | 3.5M | 2.64 | |
| Garrison Capital | 9.5 | $7.8M | 1.2M | 6.43 | |
| Kala Pharmaceuticals | 8.1 | $6.6M | 1.4M | 4.89 | |
| Molecular Templates | 8.0 | $6.6M | 1.6M | 4.04 | |
| Cm Fin | 7.8 | $6.4M | 1.0M | 6.25 | |
| Alerian Mlp Etf | 4.4 | $3.6M | 412k | 8.73 | |
| Spdr S&p 500 Etf (SPY) | 4.2 | $3.5M | 14k | 249.89 | |
| Scynexis | 2.5 | $2.1M | 4.3M | 0.48 | |
| Berkshire Hathaway (BRK.B) | 2.3 | $1.9M | 9.3k | 204.15 | |
| Jbg Smith Properties (JBGS) | 0.9 | $778k | 22k | 34.81 | |
| Alcentra Cap | 0.6 | $487k | 75k | 6.47 | |
| Kura Oncology (KURA) | 0.6 | $461k | 33k | 14.04 | |
| Aclaris Therapeutics (ACRS) | 0.6 | $453k | 61k | 7.39 | |
| Eiger Biopharmaceuticals | 0.5 | $444k | 44k | 10.16 | |
| Fs Investment Corporation | 0.5 | $421k | 81k | 5.18 | |
| ArQule | 0.4 | $345k | 124k | 2.77 | |
| Intec Pharma | 0.4 | $318k | 42k | 7.53 | |
| Marker Therapeutics Ord | 0.4 | $296k | 53k | 5.55 | |
| Ares Capital Corporation (ARCC) | 0.3 | $273k | 18k | 15.55 | |
| Far Pt Acquisition Corp cl a founders sh | 0.3 | $262k | 27k | 9.66 | |
| Spring Bk Pharmaceuticals In | 0.3 | $219k | 21k | 10.41 | |
| Marinus Pharmaceuticals | 0.2 | $176k | 61k | 2.86 | |
| Dicerna Pharmaceuticals | 0.2 | $149k | 14k | 10.68 | |
| Cti Biopharma | 0.1 | $91k | 124k | 0.73 |
